A pharmaceutical formulation plant turns active ingredients and excipients into tablets, capsules, syrups, ointments and powders under revised Schedule M GMP. Promoters usually set one up to serve pharma marketing companies on loan licence, to build own brands, to supply government tenders or to export. A pharmaceutical formulation plant consultant helps you fix the dosage forms, the layout and the compliance route before money is committed. NPCS supports this planning with project reports, feasibility studies and technical guidance.
Pharmaceutical Formulation Plant at a Glance
| Typical capacity | Line-dependent, e.g. tens of crores of tablets per year per line |
|---|---|
| Land | ~1–5 acres |
| Power load | ~300 kW–2 MW (HVAC-heavy) |
| Water | Moderate, purified water; ETP |
| Manpower | ~50–300 |
| Indicative investment | ~₹15–100 crore (Schedule M compliant; export GMP higher) |
Investment basis: excludes land.
Figures are indicative ranges. Your project report works them out for your capacity and location.
Market Demand for Pharmaceutical Formulation Plants in India
Demand for formulation capacity in India comes from three directions: domestic pharma growth, contract-manufacturing outsourcing and exports. Many marketing companies don't run their own plants, so they rely on third-party units. Demand for some therapies is seasonal, which affects how you plan production and stock. Manufacturing is concentrated in Baddi in Himachal Pradesh, Ahmedabad and Vadodara, Hyderabad, Sikkim, Uttarakhand, Maharashtra, Goa and Indore.
- Pharma marketing companies using loan licence manufacturing
- Distributors and own-brand sellers
- Government tenders such as Jan Aushadhi and state medical corporations
- Export buyers, where potential is high
Pharmaceutical Formulation Products You Can Make
Most new units start with oral solid dosage forms, mainly plain or coated tablets and capsules, because buyers for them are easy to find. Liquids, ointments and sachets can follow as separate lines. Beta-lactams need a dedicated block, so decide early whether you will ever make them.
- Tablets (plain, coated), capsules, oral liquids and syrups, dry syrups and powders, ointments/creams/gels, sachets
- Dedicated blocks for beta-lactams
- Nutraceuticals
Pharmaceutical Formulation Plant Process
The pharmaceutical formulation plant process starts in dispensing booths, where each ingredient is weighed against the batch record. Powders are granulated, dried and blended before they go to compression or capsule filling. Tablets may then be coated, inspected and packed in blister, strip or bottle. Liquids follow a shorter route of mixing, filtration, filling and sealing.
Quality is controlled at every stage rather than only at the end. Batches are released after pharmacopoeial tests such as assay, dissolution, disintegration, related substances and microbial limits. Stability studies and process validation support each product. Export units may also need WHO-GMP, EU or US FDA standards.
- Dispensing
- Granulation (wet/dry)
- Drying
- Blending
- Compression or capsule filling
- Coating
- Inspection
- Primary packing (blister/strip/bottle)
- Secondary packing. Liquids: mixing
- Filtration
- Filling and sealing. QC release at each stage
Raw Materials and Machinery for a Formulation Plant
Your main inputs are APIs and excipients, along with capsule shells, blister foil, PVC/PVDC film, bottles and cartons. API makers in Gujarat, Telangana, Maharashtra and Himachal Pradesh supply much of the domestic requirement, and some APIs are imported. Spend most of your machinery planning on HVAC, the purified-water system and the QC lab, since Schedule M compliance depends on them.
- Dispensing booths
- Rapid mixer granulator
- Fluid bed dryer
- Blenders
- Compression and capsule-filling machines
- Coating pans
- Blister packing
- Liquid tanks and filling lines
- HVAC/AHUs
- Purified-water system
- QC lab (HPLC
- Dissolution)
Pharmaceutical Formulation Plant Licence and Approvals
Approvals follow a clear order. Register the unit first, then obtain consent to establish from the State Pollution Control Board before construction, since the category is Orange. Next comes the drug manufacturing licence from the State Licensing Authority, with product permissions. After that, apply for consent to operate. Add the extra approvals below only where they apply.
- CDSCO approval for new drugs
- WHO-GMP certificate for exports
- DPCO and NPPA price compliance for scheduled formulations
- FSSAI licence for nutraceutical lines only
| Pollution category | Pharmaceutical formulation: Orange (CPCB Jan-2025 Annexure-I S.No. 123.3; 123.4 on cleaner fuel) |
|---|---|
| HSN code | 3004 (medicaments in measured doses) |
| GST | Most medicines: 5% (from 12%) w.e.f. 22-09-2025; a list of specified life-saving drugs is Nil |
| BIS / quality control order | No QCO; Drugs and Cosmetics Act and revised Schedule M apply |
| FSSAI | Required only for nutraceutical/food-supplement lines |
| Other licences | Drug manufacturing licence from the State Licensing Authority with product permissions; CDSCO approval for new drugs; WHO-GMP certificate for exports; DPCO/NPPA price compliance for scheduled formulations |
Choosing the Right Pharmaceutical Formulation Technology and GMP Level
Revised Schedule M GMP is mandatory for every unit, including MSMEs, so it is your baseline. If you plan to export, WHO-GMP, EU or US FDA standards raise the design and investment level. Beta-lactams and hormones need dedicated facilities. In practice, a domestic-focused unit can start at Schedule M and be designed so that it can be upgraded later, if export buyers come in.
Where to Set Up Your Pharmaceutical Formulation Plant
Location decides your access to API suppliers, skilled staff and loan-licence clients. Baddi in Himachal Pradesh, Ahmedabad and Vadodara, and Hyderabad are established clusters, and API makers in Gujarat, Telangana and Maharashtra are close to them. Sikkim, Uttarakhand, Goa and Indore are other options. Compare each site on land cost, utilities and the nearest client base before you choose.
Government Schemes and Project Finance for Formulation Units
The revamped Pharmaceutical Technology Upgradation Assistance Scheme is meant to help MSMEs meet Schedule M. PRIP supports R&D. A well-built project report shows lenders your cost, working capital and returns clearly. NPCS reports are used for bank loans and programmes such as PMEGP, MSME schemes, Mudra and NABARD-linked projects, subject to each lender's requirements.
What Decides Success in a Pharmaceutical Formulation Plant
Good operators treat compliance as the core of the business, not a cost. Plan for the risks below from the start, including the safe incineration of rejected batches, which are hazardous.
- Strict GMP compliance and clean regulatory documentation
- A steady client portfolio, not one buyer
- Strong QC capability
- Schedule M upgrade capex and price controls
- Not-of-standard-quality risk and competition
How NPCS Helps You Set Up a Pharmaceutical Formulation Plant
NPCS works through the decisions that shape your plant: dosage forms, capacity, GMP level, layout and machinery. Our team supports machinery selection and technical specifications, vendor selection and plant layout, and guides installation and commissioning. We also prepare the pharmaceutical formulation plant project report that your bank and approving authorities will review.
NPCS's published client list records 35 assignments on pharmaceutical projects between 2012 and 2025 for clients in 11 states and 11 countries, including detailed project reports, bankable project reports and techno-economic feasibility studies.
What Your Pharmaceutical Formulation Plant Project Report Covers
- Project introduction and BIS specifications
- Manufacturing process with flow sheet
- Market survey (demand, imports/exports, existing units)
- Personnel
- Plant and machinery with suppliers
- Land and building with layout
- Raw materials with sources and rates
- Financials (project cost, working capital, cost of production, profitability, break-even, 5–10 year cash flow, projected balance sheet, IRR/NPV/payback)
Pharmaceutical Formulation Plant: Frequently Asked Questions
How much does it cost to set up a pharmaceutical formulation plant in India?
An indicative investment is about ₹15–100 crore for a Schedule M compliant unit, excluding land. Export GMP standards cost more. The final figure depends on dosage forms, capacity and HVAC needs, which your project report works out for your plan.
Which licences and pollution category apply to a formulation plant?
You need a drug manufacturing licence from the State Licensing Authority, with product permissions. The unit falls in the Orange pollution category. CDSCO approval applies to new drugs, and a WHO-GMP certificate is needed for exports.
How much land and power does a pharmaceutical formulation plant need?
Typically about 1–5 acres of land and about 300 kW–2 MW of power, depending on capacity and lines. The load is heavy because of HVAC. Water needs are moderate, mainly purified water, and an ETP is required.
How do I start a pharmaceutical formulation plant business?
Begin by choosing dosage forms and your market: loan licence, own brand, tenders or export. Then fix the location and GMP level, prepare a project report, secure finance and approvals, and place machinery orders. Hire a consultant before you buy land.
How does NPCS help with a pharmaceutical formulation plant?
NPCS prepares detailed and bankable project reports and feasibility studies. Our team also guides on machinery, vendors, layout and commissioning. Share your planned products and location, and we will outline the cost and approvals for your project.